Literature DB >> 21124279

Hybrid procedures for peripheral obstructive disease.

A M Schrijver1, F L Moll, J P Pm De Vries.   

Abstract

The incidence and prevalence of high-risk patients suffering from critical limb ischemia due to multilevel arterial obstructive disease is growing rapidly. Invasive surgical procedures to restore inflow to the crural and pedal circulation in case of TransAtlantic InterSociety Consensus C and D (TASC) lesions of the iliacofemoral arteries are related with substantial morbidity and mortality. The mid-term and long-term outcomes of sole percutaneous revascularization procedures are disappointing for TASC C and D lesions. Hybrid endovascular and open surgical revascularization procedures might be of benefit because of its less invasive character, no need for extensive venous graft material, and the ability to overcome long-segment arterial obstructions. The common femoral artery (CFA) plays a central role in most of the hybrid procedures. CFA desobstruction, in combination with open iliac angioplasty or open superficial femoral artery (SFA) angioplasty, and CFA desobstruction with remote endarterectomy of the superficial femoral artery, are commonplace. Another valuable hybrid technique is open angioplasty of the SFA and one-staged distal origin bypass grafting. Hybrid techniques can safely be performed in the vascular operating room providing that the inventory is equipped for endovascular interventions. Vascular surgeons with thorough experience in open transluminal angioplasty, whether or not in cooperation with interventional radiologists or angiologists, will have the lead in the preoperative and perioperative planning. No randomized controlled trials have been published comparing hybrid techniques and open surgical reconstructions, or sole endvascular methods for multilevel peripheral arterial disease. During the last decade, multiple prospective and retrospective series have been reported concerning hybrid techniques, all with good initial technical success (up to 95%) and acceptable 30-day morbidity and mortality rates. Mid-term and long-term patency rates are comparable with the more invasive sole surgical revascularization procedures. The results of the endovascular part of the hybrid procedures are still influenced by the extent of the obstructions (best results in TASC A and B lesions), and patency rates of bypasses are inversely associated with increasing length of the conduit. A review of the literature concludes that hybrid techniques for the treatment of severe lower extremity arterial disease provide less invasive, long lasting, and reliable therapeutic options tailored to the needs of high-risk patients and should be in the armamentarium of today's vascular surgeon.

Entities:  

Mesh:

Year:  2010        PMID: 21124279

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  9 in total

Review 1.  [Occlusion of the aorta and iliac arteries].

Authors:  J Kosan; H Riess; G Atlihan; H Diener; T Kölbel; E S Debus
Journal:  Chirurg       Date:  2014-09       Impact factor: 0.955

2.  The Diagnosis and Treatment of Peripheral Arterial Vascular Disease.

Authors:  Holger Lawall; Peter Huppert; Christine Espinola-Klein; Gerhard Rümenapf
Journal:  Dtsch Arztebl Int       Date:  2016-10-28       Impact factor: 5.594

3.  Hybrid treatment for lower limb revascularization in a patient with vascular graft infection: a case report.

Authors:  Eduardo Lichtenfels; Nilon Erling; Newton Roesch Aerts; Andre Silvestri Reitz da Costa
Journal:  J Vasc Bras       Date:  2022-05-10

4.  Therapeutic effect of liposomal prostaglandin E1 in acute lower limb ischemia as an adjuvant to hybrid procedures.

Authors:  Jianlin Li; Bing Wang; Yue Wang; Fei Wu; Panfeng Li; Yang Li; Lei Zhao; Wenjun Cui; Yu Ding; Qian An; Jiangtao Si
Journal:  Exp Ther Med       Date:  2013-04-10       Impact factor: 2.447

Review 5.  Lower extremity revascularization via endovascular and surgical approaches: A systematic review with emphasis on combined inflow and outflow revascularization.

Authors:  Jihad A Mustapha; Bynthia M Anose; Brad J Martinsen; George Pliagas; Joseph Ricotta; Christopher W Boyes; Michael S Lee; Fadi Saab; George Adams
Journal:  SAGE Open Med       Date:  2020-06-04

6.  Our experiences on endovascular and hybrid treatment of peripheral arterial diseases.

Authors:  Veysel Temizkan; Alper Uçak; İbrahim Alp; Ejder Kardeşoğlu; Arif Selçuk; Murat Fatih Can; Murat Uğur; Ahmet Turan Yılmaz
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-04-30       Impact factor: 0.332

7.  The in vivo performance of small-caliber nanofibrous polyurethane vascular grafts.

Authors:  Zuo-jun Hu; Zi-lun Li; Ling-yu Hu; Wei He; Rui-ming Liu; Yuan-sen Qin; Shen-ming Wang
Journal:  BMC Cardiovasc Disord       Date:  2012-12-03       Impact factor: 2.298

8.  Comparison of hybrid procedure and open surgical revascularization for multilevel infrainguinal arterial occlusive disease.

Authors:  Min Zhou; Dian Huang; Chen Liu; Zhao Liu; Min Zhang; Tong Qiao; Chang-Jian Liu
Journal:  Clin Interv Aging       Date:  2014-09-22       Impact factor: 4.458

9.  Open and Endovascular Treatment of Trans-Atlantic Inter-Society Consensus II D Aortoiliac Occlusive Lesions: What Determines the Rate of Restenosis?

Authors:  Chen-Yang Shen; Yun-Feng Liu; Qing-Le Li; Yong-Bao Zhang; Yang Jiao; Miltiadis E Krokidis; Xiao-Ming Zhang
Journal:  Chin Med J (Engl)       Date:  2015-11-20       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.